Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
03/2005
03/24/2005CA2537663A1 17-heterocyclic-4-azasteroid derivatives as androgen receptor modulators
03/24/2005CA2536633A1 Fused ring heterocycles as potassium channel modulators
03/24/2005CA2535221A1 Chimeric gabab receptor
03/23/2005EP1516876A1 Mediators of hedgehog signalling pathways, compositions and uses related thereto
03/23/2005EP1515969A1 Spiroindolinepiperidine derivatives
03/23/2005EP1515965A1 Phenylaminopyrimidines and their use as rho-kinase inhibitors
03/23/2005EP1515941A1 2-naphthamide derivatives
03/23/2005EP1515727A2 (halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents
03/23/2005EP1105120B1 NON-PEPTIDE GnRH AGENTS, METHODS AND INTERMEDIATES FOR THEIR PREPARATION
03/23/2005CN1599741A Thioether substituted imidazoquinolines
03/23/2005CN1599740A Amide substituted imidazopyridines
03/23/2005CN1599739A Sulfonamido substituted imidazopyridines
03/23/2005CN1599738A Urea substituted imidazopyridines
03/23/2005CN1599737A Ring fused pyrazole derivatives
03/23/2005CN1599733A N-ureido-piperidines as antagonists viii for CCR-3 receptor
03/23/2005CN1599729A HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
03/23/2005CN1599727A Aryl ether derivatives and processes for their preparation and herbicidal and desiccant compositions containing them
03/23/2005CN1599718A Sulphonamide derivatives, the preparation thereof and the application of same as medicaments
03/23/2005CN1597672A Substituierte benzoylcyclohexandione
03/23/2005CN1597667A Quinazoline derivatives as angiogenesis inhibitors
03/23/2005CN1193999C Biological medicine precursor [1,2-alpha] imidazopyridine halide and its prepn.
03/23/2005CN1193788C Beta 2-adrenergic receptor agonist
03/22/2005US6869960 Substituted with a quinolin-3-ylmethyl- group, e.g., 2,3-dihydro-1'-((2-oxo-1,2,3,4-tetrahydro-3-quinolinyl)-methyl)spiro(1H -indene-1,4'-piperidine)
03/22/2005US6869958 Fused tetrahydropyridine derivatives as matrix metalloproteinase inhibitors
03/22/2005US6869956 Such as 4-(2'-aminoethyl)amino-1,8-dimethylimidazo(1,2-a) quinoxaline; kits; treating arthritis, psoriasis, inflammatory bowel disease, autoimmune diseases and neurodegenerative diseases among others
03/22/2005US6869955 Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
03/22/2005US6869949 Such as 8-hydroxy-2,3-dimiethyl-9-(3-thienyl)-7,8,9,10-tetrahydroimidazo(1,2 -h)(1,7)napththyridin-7-one
03/22/2005US6869946 For therapy of disease or condition in a mammal, wherein the alpha 7 nicotinic acetylcholine receptor is implicated and for therapy of diseases where there is a sensory-gating deficit in a mammal
03/22/2005US6869943 Sorbitol dehydrogenase inhibitors
03/22/2005US6869466 Cucurbiturils and method for binding gases and volatiles using cucurbiturils
03/22/2005CA2330092C Benzimidazole compounds as orl1-receptor agonists
03/17/2005WO2005023810A1 Spirohydantoin compounds and methods for the modulation of chemokine receptor activity
03/17/2005WO2005023809A1 Spiro compounds and methods for the modulation of chemokine receptor activity
03/17/2005WO2005023808A2 Process for the preparation of renzapride and intermediates thereof
03/17/2005WO2005023807A2 4 - heterobicyclyamino - substituted quinazolines and analogues therof as capsaicin - antagonists
03/17/2005WO2005023806A2 Heteroaryl fused pyridines, pyrazines and pyrimidines as crf1 receptor ligands
03/17/2005WO2005023805A1 Benzoquinolizine-2-carboxylic acid arginine salt tetrahydrate
03/17/2005WO2005023760A2 Metal complexes of n-heterocyclic carbenes as radiopharmaceuticals and antibiotics
03/17/2005WO2005023759A2 Heterocyclic inhibitors of mek and methods of use thereof
03/17/2005WO2005023255A2 Use of indole-derived compounds for the preparation of a medicament that can be used to treat diseases related to the splicing process
03/17/2005WO2005023246A1 Substituted indoles as inhibitors of poly (adp-ribose) polymerase (parp)
03/17/2005WO2005007652A3 Substituted quinolin-4-ylamine analogues
03/17/2005WO2004103305A3 Spiropyrazole compound
03/17/2005WO2004074270B1 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
03/17/2005WO2004072033A3 Pyrazoles and methods of making and using the same
03/17/2005WO2004058759A8 Aryl / hetaryl substituted imidazoquinolines
03/17/2005WO2003080606A8 Process for preparing a pharmaceutically active compound (granisetron)
03/17/2005US20050059823 quinazolinone compounds such as 2-cyclopropyl-4-oxo-3-((p-fluorobenzyl)carbonylamino)-7-fluoro-1,2-dihydroquinazoline; brain and nervous system disorders such as mood disorders or neuropathic pain
03/17/2005US20050059729 Substituted cyclic compounds
03/17/2005US20050059722 Kinase inhibitors, such as focal adhesion kinase (FAK) inhibitors; treating cancer; 2-methylsulfonyl-N-(3-thiophen-2-yl-1H-indazol-5-yl)benzenesulfonamide for example
03/17/2005US20050059714 2-Cyclopropyl-4-(5-fluoro-2-methoxyphenyl)-4-methyl-1-(1H-pyrrolo[2,3-c]pyridin-2-yl)pentan-2-ol; treating diseases of inflammatory, allergic, or proliferative condition; type II diabetes, obesity, cardiovascular diseases, hypertension, arteriosclerosis, neurological diseases, adrenal and pituitary tumor
03/17/2005US20050059712 Immunosuppressants for treating skin disorders, acne, alopecia, estrogen- or androgen-dependent tumors, rheumatoid arthritis, type I and II diabetes, lupus erythematosus, multiple sclerosis, ulcerative colitis, Crohn's disease, psoriasis, contact dermatitis, graft versus host disease, eczema, asthma
03/17/2005US20050059695 Azaindole piperazine diamides as drugs for treatment of Aids or Hiv
03/17/2005US20050059687 Modulators of ATP-Binding Cassette transporters
03/17/2005US20050059685 such as R)-1,5-Dimethyl 3-(5-hydroxyhexyl)pyrido[2,3-d]pyrimidine-2,4,7(1H,3H,8H)-trione, used for the treatment or prevention of symptoms or manifestations associated with diseases or disorders affected by cytokine intracellular signaling
03/17/2005US20050059677 Pyralopyridines, process for their preparation and use as therapeutic compounds
03/17/2005US20050059670 Isethionate salt of a selective CKD4 inhibitor
03/17/2005US20050059663 4-{3-[4-(6-Chlorobenzothiazol-2-yl)-1,4-diazepan-1-ylcarbonyl]benzyl}-1(2H)-phthalazinone; Cancer, BRCA deficient
03/17/2005US20050059662 Substituted quinazolinone compounds
03/17/2005US20050059653 Novel crystalline forms of 11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido [3,2-b: 2',3'-e][1,4] diazepin-6-one (nevirapine)
03/17/2005US20050059650 1H-pyrazolo[3,4-d]pyrimidine derivatives as antidiabetic and antiobesity agent
03/17/2005US20050058635 Anticancer agents; therapy for infections; administering glutaminyl cyclase inhibitor; Alzheimer's disease; Down syndrome; controlling fertility; schizophrenia; skin disorders
03/17/2005DE10337942A1 Aminobenzimidazolderivate Aminobenzimidazolderivate
03/17/2005CA2579609A1 Spirohydantoin compounds and methods for the modulation of chemokine receptor activity
03/17/2005CA2579608A1 Spiro compounds and methods for the modulation of chemokine receptor activity
03/17/2005CA2537883A1 Substituted bicyclic quinazolin-4-ylamine derivatives
03/17/2005CA2537829A1 Heteroaryl fused pyridines, pyrazines and pyrimidines as crf1 receptor ligands
03/17/2005CA2537752A1 Use of indole-derived compounds for the preparation of a medicament that can be used to treat diseases related to the splicing process
03/17/2005CA2537677A1 Metal complexes of n-heterocyclic carbenes as radiopharmaceuticals and antibiotics
03/17/2005CA2537536A1 Process for the preparation of renzapride and intermediates thereof
03/17/2005CA2537321A1 Heterocyclic inhibitors of mek and methods of use thereof
03/17/2005CA2537097A1 Substituted indoles as inhibitors of poly (adp-ribose) polymerase (parp)
03/16/2005EP1514870A1 Prodrug and process for producing the same
03/16/2005EP1514552A1 Novel fused imidazole derivative
03/16/2005EP1513844A1 Novel interleukin-1 beta converting enzyme inhibitors
03/16/2005EP1513842A1 Substituted hexahydropyrrolo (1,2-a)pyrazines, octahydropyrido(1,2-a)pyrazines and decahydropyrazino(1,2-a)azepines
03/16/2005EP1513841A1 1,6,9,14-tetrasubstituted terrylene tetracarboxylic acid diimides
03/16/2005EP1513840A2 Compounds and compositions for the treatment of diabetes and diabetes-related disorders
03/16/2005EP1513832A2 Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides
03/16/2005EP1513828A1 New compounds useful for the treatment of obesity, type ii diabetes and cns disorders
03/16/2005EP1513820A2 Compounds, compositions, and methods
03/16/2005EP1513810A1 4-(aryl or heteroaryl) -2-butylamine derivatives and their use as glucocorticoid ligans
03/16/2005EP1513527A1 Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers
03/16/2005EP1513524A2 Ether substituted imidazopyridines
03/16/2005EP1399436B1 Oxytocin agonists
03/16/2005EP1362081B1 Acid pigment dispersants and pigment preparations
03/16/2005EP1226119B1 Tyrosine kinase inhibitors
03/16/2005EP0758324B1 Substituted aromatic thiocarboxylic acid amides and their use as herbicides
03/16/2005CN1596263A Aryl fused azapolycyclic compounds
03/16/2005CN1596255A Chemokine receptor binding heterocyclic compounds with enhanced efficacy
03/16/2005CN1596240A Chalcone derivatives and their use to treat diseases
03/16/2005CN1193029C New 7-amino pyrido[2, 3-d] pyrimidine derivative, its composition and use
03/16/2005CN1193028C Dual molecules containing peroxide derivative; synthesis and therapeutic applications thereof
03/16/2005CN1193026C Z-pyrazoline-5-ones
03/15/2005US6867298 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency
03/15/2005US6867222 Nociceptin analogs
03/15/2005US6867211 Fused nitrogen biheterocyclic derivatives; immunomodulaters; inhibiting cytokine release
03/15/2005US6867209 Indole-type derivatives as inhibitors of p38 kinase
03/15/2005US6867208 Vitronectin receptor antagonists, their preparation and their use
03/15/2005US6867202 Treatment of insulin resistance
1 ... 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 ... 646